captopril has been researched along with ramipril in 111 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 26 (23.42) | 18.7374 |
1990's | 34 (30.63) | 18.2507 |
2000's | 30 (27.03) | 29.6817 |
2010's | 20 (18.02) | 24.3611 |
2020's | 1 (0.90) | 2.80 |
Authors | Studies |
---|---|
Abbenante, G; Fairlie, DP; Leung, D | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Auch-Schwelk, W; Bossaller, C; Claus, M; Fleck, E; Graf, K; Gräfe, M | 1 |
Brée, F; Hamon, G; Tillement, JP | 1 |
Düsing, R; Hoffmann, G | 1 |
Becker, RH; Schölkens, BA; Wiemer, G | 1 |
Lüders, S; Ruschitzka, F; Scheler, F; Schoel, G; Schrader, J | 1 |
Blair-West, JR; Denton, DA; McKinley, MJ; Weisinger, RS | 1 |
Cushman, DW; Dzwonczyk, S; Fung, W; Grover, GJ; Sleph, PG; Tobias, D; Wang, P | 1 |
Becker, BF; Gerlach, E; Leipert, B; Raschke, P; Reinholz, N | 1 |
Cachofeiro, V; Nasjletti, A; Sakakibara, T | 1 |
Kranzhöfer, R; Richardt, G; Schömig, A | 1 |
Beliakova, EV; Masenko, VP; Nasonov, EL; Oshchepkova, EV; Panfilov, VV; Vil'chinskaia, MIu; Zharova, EA | 1 |
Inagami, T; Mikami, H; Nakamaru, M; Ogihara, T; Rakugi, H; Saito, H | 1 |
Giesen-Crouse, EM; Imbs, JL; Krieger, JP; Schmidt, M; Welsch, C | 1 |
de Graeff, PA; de Langen, CD; Scholtens, E; van Gilst, WH; van Wijngaarden, J; Wesseling, H | 1 |
Baudin, B; Drouet, L | 1 |
Chen, X; Deng, HW; Li, DY; Li, YJ; Pi, XJ | 1 |
de Graeff, PA; Kingma, JH; Lie, KI; Viersma, JW; Wesseling, H | 1 |
Iimura, O; Shimamoto, K | 1 |
Cushman, DW; DeForrest, JM; Fung, WC; Grover, GJ; Harvey, CM; Mitch, SL; Scalese, RJ; Wang, FL | 1 |
Brunner, HR; Nussberger, J; Waeber, B | 1 |
Chen, X; Pi, XJ | 1 |
Fregly, MJ; Rowland, NE | 1 |
Mauersberger, H; Witte, PU | 1 |
Bührle, CP; Rosivall, L; Taugner, R | 1 |
Dietz, R; Hackenthal, E; Kübler, W; Manthey, J; Osterziel, KJ; Röhrig, N; Schmidt-Gayk, H | 1 |
Giesen-Crouse, E; Imbs, JL; Krieger, JP; Schmidt, M; Welsch, C | 1 |
Hackenthal, E; Hilgenfeldt, U; Radziwill, R; Stuzmann, M | 1 |
Vierhapper, H; Waldhäusl, W; Witte, PU | 1 |
Bouthier, JD; Laurent, SL; London, GM; Mimran, AR; Safar, ME | 1 |
Walter, U; Witte, PU | 1 |
Doussau, MP; Giudicelli, JF; Richer, C | 1 |
de Graeff, PA; Dunselman, PH; Kingma, JH; Lie, KI; Wesseling, H | 1 |
Ganten, D; Lang, RE; Unger, T | 1 |
Maier, R; Metzger, H; Sitter, C; Stern, HO | 1 |
Bünning, P | 1 |
Becker, RH; Metzger, M; Schölkens, BA; Schulze, KJ | 1 |
Schölkens, BA; Tilly, H; Xiang, JZ | 1 |
Schacht, U | 1 |
Acharya, HK; Vakil, HB; Vatsraj, DJ; Vyas, NR; Yajnik, NV; Yajnik, VH | 1 |
Miselis, J; Siminiak, T; Wysocki, H | 1 |
Chen, K; Zimmerman, BG | 1 |
McDaniel, PA; Riddle, MC | 1 |
Mazzotta, G; Vecchio, C | 1 |
Andrén, L; Hedner, T; Lindholm, L; Lötvall, J; Lunde, H; Samuelsson, O; Wiholm, BE | 1 |
Iimura, O; Miki, T; Miura, T; Sakamoto, J; Shimamoto, K; Urabe, K | 1 |
Bauer, R; Carvalho, E; Danielsen, E; Göthe, PO; Hemmingsen, L | 1 |
Dunham, EW; Zhang, X; Zimmerman, BG | 1 |
Hofmann, S; Kersten, U | 1 |
Hintze, TH; Nasjletti, A; Wolin, MS; Xie, YW; Xu, X; Zhang, X | 1 |
Arabidze, GG; Filatova, EV; Kukharchuk, VV; Rogoza, AN; Vikhert, OA | 1 |
Hamlin, R; Mandigers, PJ; Pijpers, FS | 1 |
Black, SC; Driscoll, EM; Lucchesi, BR | 1 |
Gerasimenko, OI; Kutyrina, IM; Shvetsov, MIu; Tareeva, IE | 1 |
Kukushkin, SK; Lebedev, AV; Manoshkina, EM; Shamarin, VM | 1 |
Claridge, S; Hanessian, S; Reinhold, U; Saulnier, M | 1 |
Akarawut, W; Lin, CJ; Smith, DE | 1 |
Baudin, B; Bénéteau-Burnat, B | 1 |
Berger, R; Frey, B; Kozanly, I; Kuchling, G; Pacher, R; Stanek, B | 1 |
Bazhukhina, IF; Drozdov, VV; Gapon, LI; Sergeĭchik, OI; Spitsina, NA; Teffenberg, DV; Vershinina, AM | 1 |
Gallardo, J; García-Robles, R; Rodríguez-García, JL; Serrano, M; Villa, E | 1 |
Dvorak, SR | 1 |
Luft, FC | 1 |
Kumar, V | 1 |
Bässler, A; Fischer, M; Hengstenberg, C; Holmer, S; Klein, G; Löwel, H; Mayer, B; Riegger, G; Schunkert, H | 1 |
Francis, GS; Gassler, JP | 1 |
Haas, GJ | 1 |
Agarwal, A; Anuradha, S; Rizvi, SN; Singh, NP; Uppal, M | 1 |
Ditiatkov, AE; Radzevich, AE; Tikhonov, VA | 2 |
Larger, E; Marre, M | 1 |
Studney, D | 1 |
Bicket, DP | 1 |
Bartels, T; Dominiak, P; Häuser, W; Raasch, W; Rütten, H; Schwartz, C | 1 |
Bennett, HA; Bonari, L; Einarson, TR; Han, D; Hemels, ME; Traverso, ML | 1 |
Karkishchenko, NN; Makliakov, IuS; Sarbilina, IV | 1 |
Deev, AD; Kukushkin, SK; Lebedev, AV; Manoshkina, EM; Shamarin, VM | 1 |
Gardiner, G; Guindi, M; Joshi, S; Shiota, K; Wanless, IR; Wong, FS; Yeung, E | 1 |
Kvan, E; Reikvam, A | 1 |
Keltai, M | 1 |
Cohen-Solal, A; Dietz, R; Eichhorn, E; Erhardt, L; Hobbs, FD; Krum, H; Maggioni, A; McKelvie, RS; McMurray, J; Piña, IL; Soler-Soler, J; Swedberg, K | 1 |
Kuster, DJ; Marshall, GR | 1 |
Gottsäter, A; Ohlin, AK; Ohlin, H; Tingberg, E | 1 |
Bertoluci, MC; Oliveira, FR; Schmid, H; Schmidt, A; Thomazelli, FC; Uebel, D | 1 |
Bauriedel, G; Lüderitz, B; Nickenig, G; Schneider-Schmitt, M; Skowasch, D; Viktor, A | 1 |
Babar, S; Ducobu, J; Legssyer, I; Moguilevsky, N; Moreau, P; Nève, J; Van Antwerpen, P; Vanhaeverbeek, M; Zouaoui Boudjeltia, K | 1 |
Boccioletti, V; Cominacini, L; Fabrizzi, P; Garbin, U; Lo Cascio, V; Luchetta, ML; Nava, MC; Pasini, AF; Pellegrini, M; Stranieri, C | 1 |
Cialdai, C; Giuliani, S; Maggi, CA; Tramontana, M; Valenti, C | 1 |
Bongianni, F; Cinelli, E; Evangelista, S; Mutolo, D; Pantaleo, T | 1 |
Chou, J; Debanne, SM; Fang, JC; Mishra, P; Simon, DI; Sipahi, I | 1 |
Cakir, M; Coban, MK; Coskun, S; Hacimuftuoglu, A; Saruhan, F; Sengul, G | 1 |
Ambrosio, G; Ambrosioni, E; Borghi, C; Novo, S; Vinereanu, D | 1 |
Ambrosio, G; Ambrosioni, E; Bacchelli, S; Borghi, C; Cicero, AF; Esposti, DD; Omboni, S; Vinereanu, D; Zava, D | 1 |
Borghi, C; Cicero, AF; Cosentino, ER; Rinaldi, ER | 1 |
Cohen, EP; Fish, BL; Moulder, JE | 1 |
Chang, CH; Lai, MS; Lee, YC; Lin, JW; Lin, MS; Ruan, SY; Wu, LC | 1 |
Ambrosio, G; Ambrosioni, E; Borghi, C; Novo, S; Omboni, S; Vinereanu, D | 4 |
Ali, MJ; Bradley, JM; Cirino, G; Donnarumma, E; Evangelista, S; Goodchild, TT; Islam, KN; Jenkins, JS; Lefer, DJ; Organ, CL; Patel, RA; Polhemus, DJ; Rushing, AM; Scarborough, AL | 1 |
Ambrosioni, E; Bacchelli, S; Borghi, C; Esposti, DD; Omboni, S; Reggiardo, G | 1 |
Ababei, DC; Bild, V; Bild, W; Ciobică, A; Lefter, RM; Rusu, RN | 1 |
Ahmad, HA; Al Farabi, MJ; Azmi, Y; Gandi, P; Givani, CL; Lumeno, ISP; Oktaviono, YH | 1 |
15 review(s) available for captopril and ramipril
Article | Year |
---|---|
Protease inhibitors: current status and future prospects.
Topics: Animals; Aspartic Acid Endopeptidases; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Humans; Metalloendopeptidases; Models, Molecular; Protease Inhibitors; Serine Endopeptidases; Serine Proteinase Inhibitors | 2000 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
The present molecules of converting enzyme inhibitors.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzazepines; Blood Pressure; Bridged Bicyclo Compounds; Captopril; Cilazapril; Cyclopentanes; Dipeptides; Enalapril; Humans; Indoles; Lisinopril; Perindopril; Pyridazines; Ramipril; Renin-Angiotensin System | 1985 |
Effect of converting enzyme inhibitors on hypertensive large arteries in humans.
Topics: Angiotensin-Converting Enzyme Inhibitors; Brachial Artery; Bridged Bicyclo Compounds; Captopril; Carotid Arteries; Enalapril; Humans; Hypertension; Ramipril | 1986 |
[Angiotensin converting enzyme inhibitors during acute phase of myocardial infarct].
Topics: Administration, Oral; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Clinical Trials as Topic; Enalapril; Female; Humans; Injections, Intravenous; Lisinopril; Male; Multicenter Studies as Topic; Myocardial Infarction; Nitroglycerin; Ramipril; Thrombolytic Therapy; Time Factors | 1994 |
ACE inhibitors: new hope for old drugs?
Topics: Angina, Unstable; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Diabetes Mellitus, Type 2; Humans; Myocardial Infarction; Ramipril; Risk Factors | 2000 |
Angiotensin-converting enzyme inhibitors in antihypertensive therapy.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Humans; Hypertension; Myocardial Infarction; Ramipril; Risk Factors | 2000 |
Management of asymptomatic left ventricular dysfunction.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Coronary Disease; Drug Therapy, Combination; Echocardiography; Enalapril; Female; Heart Failure; Humans; Hypertension; Indoles; Male; Middle Aged; Myocardial Infarction; Norepinephrine; Ramipril; Randomized Controlled Trials as Topic; Retrospective Studies; Risk Factors; Ventricular Dysfunction, Left; Ventricular Function, Left | 2001 |
Angiotensin blockade in type 2 diabetes: what the new evidence tells us about renal and cardiac complications.
Topics: Albuminuria; Amlodipine; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Biphenyl Compounds; Calcium Channel Blockers; Captopril; Cardiovascular Diseases; Clinical Trials as Topic; Diabetes Complications; Diabetes Mellitus; Diabetic Angiopathies; Diabetic Nephropathies; Humans; Irbesartan; Kidney Diseases; Losartan; Prognosis; Ramipril; Tetrazoles | 2002 |
Using ACE inhibitors appropriately.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzazepines; Captopril; Cardiovascular Diseases; Clinical Trials as Topic; Contraindications; Diabetic Nephropathies; Drug Costs; Enalapril; Fosinopril; Heart Failure; Humans; Hypertension; Indoles; Isoquinolines; Lisinopril; Meta-Analysis as Topic; Myocardial Infarction; Perindopril; Quinapril; Ramipril; Renin-Angiotensin System; Risk; Tetrahydroisoquinolines; United States | 2002 |
[Preventive therapy with ACE inhibitors for coronary patients].
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Clinical Trials as Topic; Coronary Disease; Death, Sudden, Cardiac; Enalapril; Humans; Indoles; Lisinopril; Myocardial Infarction; Perindopril; Ramipril; Treatment Outcome | 2004 |
[The use of angiotensin converting enzyme inhibitors in patients after myocardial infarction].
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Diabetes Complications; Enalapril; Heart Failure; Humans; Indoles; Middle Aged; Myocardial Infarction; Ramipril; Randomized Controlled Trials as Topic; Time Factors; Treatment Outcome; Ventricular Dysfunction | 2008 |
Meta-analysis of randomized controlled trials on effect of angiotensin-converting enzyme inhibitors on cancer risk.
Topics: Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Captopril; Enalapril; Fosinopril; Humans; Lisinopril; Neoplasms; Quinapril; Ramipril; Randomized Controlled Trials as Topic; Tetrahydroisoquinolines | 2011 |
Efficacy and Safety of Zofenopril Versus Ramipril in the Treatment of Myocardial Infarction and Heart Failure: A Review of the Published and Unpublished Data of the Randomized Double-Blind SMILE-4 Study.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Double-Blind Method; Heart Failure; Humans; Myocardial Infarction; Ramipril; Randomized Controlled Trials as Topic; Treatment Outcome | 2018 |
Effects of the concomitant administration of xanthine oxidase inhibitors with zofenopril or other ACE-inhibitors in post-myocardial infarction patients: a meta-analysis of individual data of four randomized, double-blind, prospective studies.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Double-Blind Method; Enzyme Inhibitors; Female; Humans; Lisinopril; Male; Middle Aged; Myocardial Infarction; Progression-Free Survival; Prospective Studies; Ramipril; Randomized Controlled Trials as Topic; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome; Xanthine Oxidase | 2018 |
18 trial(s) available for captopril and ramipril
Article | Year |
---|---|
[Long-term blood pressure measurement for evaluating the first dose response of captopril and ramipril in patients with a stimulated renin system].
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitors; Bridged Bicyclo Compounds; Captopril; Circadian Rhythm; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Hypertension; Male; Middle Aged; Prodrugs; Ramipril; Renin-Angiotensin System | 1992 |
Acute and chronic effects of ramipril and captopril in congestive heart failure.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Bridged Bicyclo Compounds; Bridged-Ring Compounds; Captopril; Electrolytes; Female; Heart; Heart Failure; Hemodynamics; Humans; Kidney; Male; Middle Aged; Ramipril; Random Allocation | 1989 |
Ramipril and captopril in patients with heart failure: effects on hemodynamics and vasoconstrictor systems.
Topics: Adult; Aged; Bridged Bicyclo Compounds; Bridged-Ring Compounds; Captopril; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Ramipril; Random Allocation; Renin; Vasoconstriction; Vasopressins | 1987 |
Unchanged pressor effect of norepinephrine in normal man following the oral administration of two angiotensin converting enzyme inhibitors, captopril and HOE 498.
Topics: Adult; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Bridged Bicyclo Compounds; Bridged-Ring Compounds; Captopril; Drug Interactions; Humans; Male; Norepinephrine; Ramipril; Time Factors | 1986 |
Comparative double-blind study of ramipril and captopril in mild to moderate essential hypertension.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Bridged Bicyclo Compounds; Bridged-Ring Compounds; Captopril; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Hypertension; Male; Ramipril; Random Allocation | 1987 |
Acute hemodynamic and hormonal effects of ramipril in chronic congestive heart failure and comparison with captopril.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Bridged Bicyclo Compounds; Bridged-Ring Compounds; Captopril; Chronic Disease; Heart Failure; Humans; Middle Aged; Ramipril; Random Allocation; Renin-Angiotensin System | 1987 |
Ramipril vs captopril in mild to moderate hypertension.
Topics: Adult; Aged; Blood Pressure; Captopril; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Hypertension; Male; Middle Aged; Ramipril | 1994 |
[The effectiveness and tolerance of ramipril in comparison to captopril for heart failure in dogs].
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Dog Diseases; Dogs; Female; Heart Failure; Male; Ramipril; Treatment Outcome | 1996 |
[Hemodynamic mechanisms of lupus nephritis progression].
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Captopril; Disease Progression; Female; Hemodynamics; Humans; Hypertension, Renal; Kidney; Kidney Function Tests; Lupus Nephritis; Male; Prognosis; Ramipril | 1998 |
[Ramipril effects on 24 hour profile of blood pressure in patients with mild and moderate hypertension].
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Captopril; Follow-Up Studies; Humans; Hypertension; Male; Middle Aged; Ramipril; Severity of Illness Index; Treatment Outcome | 1998 |
Prostacyclin: its pathogenic role in essential hypertension and the class effect of ACE inhibitors on prostaglandin metabolism.
Topics: 6-Ketoprostaglandin F1 alpha; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Case-Control Studies; Enalapril; Epoprostenol; Female; Fosinopril; Humans; Hypertension; Male; Middle Aged; Prostaglandins; Ramipril | 1999 |
Lipid peroxidation is not increased in heart failure patients on modern pharmacological therapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Captopril; Comorbidity; Delayed-Action Preparations; Dinoprost; Female; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Lipid Peroxidation; Losartan; Male; Malondialdehyde; Middle Aged; Myocardial Infarction; Natriuretic Peptide, Brain; Nitric Oxide Donors; Oxidative Stress; Ramipril; Stroke Volume; Ultrasonography; Ventricular Dysfunction, Left | 2006 |
Urinary TGF-beta1 reduction related to a decrease of systolic blood pressure in patients with type 2 diabetes and clinical diabetic nephropathy.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Blood Glucose; Blood Pressure; Captopril; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drug Therapy, Combination; Enalapril; Female; Follow-Up Studies; Glycated Hemoglobin; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Potassium; Propranolol; Ramipril; Transforming Growth Factor beta1 | 2006 |
Effect of sulfhydryl and non-sulfhydryl angiotensin-converting enzyme inhibitors on endothelial function in essential hypertensive patients.
Topics: Adrenergic beta-Antagonists; Adult; Angiotensin-Converting Enzyme Inhibitors; Atenolol; Blood Glucose; Blood Pressure; Captopril; Cell Adhesion Molecules; Cholesterol, HDL; Endothelium, Vascular; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Oxidative Stress; Ramipril; Sulfhydryl Compounds; Triglycerides; Vasodilation | 2007 |
Comparison between zofenopril and ramipril in combination with acetylsalicylic acid in patients with left ventricular systolic dysfunction after acute myocardial infarction: results of a randomized, double-blind, parallel-group, multicenter, European stud
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Captopril; Chi-Square Distribution; Double-Blind Method; Drug Therapy, Combination; Europe; Female; Heart Failure; Hospitalization; Humans; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Platelet Aggregation Inhibitors; Prospective Studies; Ramipril; Risk Assessment; Risk Factors; Stroke Volume; Systole; Time Factors; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Function, Left | 2012 |
Zofenopril and ramipril and acetylsalicylic acid in postmyocardial infarction patients with left ventricular systolic dysfunction: a retrospective analysis in hypertensive patients of the SMILE-4 study.
Topics: Aged; Antihypertensive Agents; Aspirin; Blood Pressure; Captopril; Europe; Female; Humans; Hypertension; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Ramipril; Randomized Controlled Trials as Topic; Retrospective Studies; Ventricular Dysfunction, Left | 2013 |
Effect of zofenopril and ramipril on cardiovascular mortality in patients with chronic heart failure.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Chronic Disease; Endpoint Determination; Female; Heart Failure; Humans; Male; Proportional Hazards Models; Prospective Studies; Ramipril; Survival Rate; Treatment Outcome | 2013 |
Zofenopril and ramipril in patients with left ventricular systolic dysfunction after acute myocardial infarction: A propensity analysis of the Survival of Myocardial Infarction Long-term Evaluation (SMILE) 4 study.
Topics: Captopril; Demography; Drug Therapy, Combination; Endpoint Determination; Female; Hospitalization; Humans; Intention to Treat Analysis; Male; Middle Aged; Myocardial Infarction; Propensity Score; Ramipril; Survival Analysis; Time Factors; Ventricular Dysfunction, Left | 2016 |
78 other study(ies) available for captopril and ramipril
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics | 2011 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Local potentiation of bradykinin-induced vasodilation by converting-enzyme inhibition in isolated coronary arteries.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine; Bradykinin; Captopril; Cattle; Coronary Vessels; Dipeptides; Enalaprilat; Endothelium, Vascular; Fosinopril; Humans; In Vitro Techniques; Lisinopril; Muscle Relaxation; Muscle, Smooth, Vascular; Nitroarginine; Ramipril; Receptors, Bradykinin; Receptors, Neurotransmitter; Vasodilation; Vasodilator Agents | 1992 |
Evidence for two binding sites on membrane-bound angiotensin-converting enzymes (ACE) for exogenous inhibitors except in testis.
Topics: Angiotensin I; Angiotensin-Converting Enzyme Inhibitors; Animals; Binding Sites; Brain; Captopril; Cell Membrane; Indoles; Lung; Male; Peptidyl-Dipeptidase A; Pyrroles; Ramipril; Rats; Rats, Inbred Strains; Testis | 1992 |
ACE-inhibition, kinins, and vascular PGI2 synthesis.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Blood Platelets; Captopril; Cyclic AMP; Cyclic GMP; Dipeptides; Epoprostenol; Female; Humans; Kallikreins; Kinins; Lisinopril; Male; Muscle, Smooth, Vascular; Ramipril; Rats; Rats, Sprague-Dawley | 1992 |
Converting enzyme inhibitor-stimulated formation of nitric oxide and prostacyclin in endothelial cells from bovine aorta is mediated by endothelium-derived bradykinin.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Arginine; Bradykinin; Captopril; Cattle; Cells, Cultured; Cyclic GMP; Endothelium, Vascular; Epoprostenol; Nitric Oxide; Nitroarginine; Ramipril | 1992 |
Thirst and brain angiotensin in cattle.
Topics: Angiotensin I; Angiotensin-Converting Enzyme Inhibitors; Animals; Body Water; Brain; Bridged Bicyclo Compounds; Captopril; Cattle; Cerebrospinal Fluid; Dehydration; Eating; Female; Injections, Intraventricular; Ramipril; Thirst | 1992 |
Effects of different angiotensin-converting enzyme (ACE) inhibitors on ischemic isolated rat hearts: relationship between cardiac ACE inhibition and cardioprotection.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Coronary Disease; Drug Stability; Enalaprilat; Fosinopril; Heart; In Vitro Techniques; Male; Myocardium; Organophosphorus Compounds; Prodrugs; Proline; Pyrroles; Ramipril; Rats; Rats, Inbred Strains; Sulfhydryl Compounds | 1991 |
[Are the radical scavenging properties of ACE inhibitors with sulfhydryl groups in therapeutically effective concentrations of quantitative significance?].
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Bridged Bicyclo Compounds; Captopril; Coronary Disease; Dose-Response Relationship, Drug; Enalapril; Guinea Pigs; Hemodynamics; Hydroxides; Hydroxyl Radical; Luminescent Measurements; Myocardial Reperfusion Injury; Pyrroles; Ramipril; Sulfhydryl Reagents; Uric Acid | 1991 |
Kinins, nitric oxide, and the hypotensive effect of captopril and ramiprilat in hypertension.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Arginine; Biphenyl Compounds; Blood Pressure; Captopril; Hypertension; Imidazoles; Kinins; Losartan; Male; Nitric Oxide; omega-N-Methylarginine; Pyrroles; Ramipril; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Tetrazoles | 1992 |
Effect of angiotensin converting enzyme inhibitors on cardiac noradrenaline release.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Coronary Disease; Heart; Male; Norepinephrine; Pyrroles; Ramipril; Rats; Rats, Inbred Strains; Sodium | 1991 |
[Immunological effects of captopril and ramipril in patients with hypertension].
Topics: Adult; Bridged Bicyclo Compounds; Bridged-Ring Compounds; Captopril; Dysgammaglobulinemia; Humans; Hypergammaglobulinemia; Hypertension; IgA Deficiency; IgG Deficiency; Immunoglobulin A; Immunoglobulin E; Immunoglobulin G; Immunoglobulin M; Immunoglobulins; Male; Ramipril | 1990 |
Effects of chronic converting enzyme inhibition on the vascular renin-angiotensin system.
Topics: Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Animals; Bridged Bicyclo Compounds; Captopril; Cilazapril; Enalapril; Male; Mesenteric Arteries; Perfusion; Pyridazines; Ramipril; Rats; Rats, Inbred Strains; Renin; Renin-Angiotensin System; Thiazepines | 1990 |
Effect of angiotensin converting enzyme inhibitors on the vasoconstrictor action of angiotensin I on isolated rat kidney.
Topics: Angiotensin I; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; In Vitro Techniques; Kidney; Kinetics; Male; Peptidyl-Dipeptidase A; Pyrroles; Ramipril; Rats; Rats, Inbred Strains; Vasoconstrictor Agents | 1986 |
Captopril-induced increase in coronary flow: an SH-dependent effect on arachidonic acid metabolism?
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Bridged Bicyclo Compounds; Captopril; Chromones; Coronary Circulation; Glutathione; In Vitro Techniques; Indomethacin; Male; Quinacrine; Ramipril; Rats; Rats, Inbred Strains; Sulfhydryl Compounds | 1987 |
In vitro interactions between ramiprilat and angiotensin I-converting enzyme in endothelial cells.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Cells, Cultured; Endothelium, Vascular; Pyrroles; Ramipril; Swine | 1989 |
Prostacyclin-mediated cardioprotection of captopril and ramiprilate against lipid peroxidation in rat.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Cells, Cultured; Epoprostenol; Free Radicals; In Vitro Techniques; Lipid Peroxidation; Myocardial Reperfusion Injury; Oxygen; Pyrroles; Ramipril; Rats; Rats, Inbred Strains | 1989 |
Significance of kallikrein-kinin and renin-angiotensin systems in the hypotensive mechanism of angiotensin-I converting enzyme inhibitors in essential hypertensives.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Bradykinin; Bridged Bicyclo Compounds; Bridged-Ring Compounds; Captopril; Diuresis; Heart Rate; Humans; Hypertension; Kallikreins; Kinins; Ramipril; Renin-Angiotensin System | 1989 |
Comparisons in vitro, ex vivo, and in vivo of the actions of seven structurally diverse inhibitors of angiotensin converting enzyme (ACE).
Topics: Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Animals; Bridged Bicyclo Compounds; Captopril; Chemotherapy, Cancer, Regional Perfusion; Dose-Response Relationship, Drug; Enalapril; Fosinopril; Heart; Hypertension; Lisinopril; Male; Organophosphorus Compounds; Proline; Ramipril; Rats; Time Factors; Tissue Distribution | 1989 |
Captopril and ramiprilat protect against free radical injury in isolated working rat hearts.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Dimethyl Sulfoxide; Disulfides; Dose-Response Relationship, Drug; Electrocardiography; Female; Free Radicals; Heart; Indomethacin; Myocardium; Pyrroles; Ramipril; Rats; Rats, Inbred Strains; Sulfhydryl Compounds; Time Factors | 1989 |
Comparison of the effects of the dipeptidyl peptidase inhibitors captopril, ramipril, and enalapril on water intake and sodium appetite of Sprague-Dawley rats.
Topics: Angiotensin I; Angiotensin II; Animals; Appetite; Brain; Bridged Bicyclo Compounds; Bridged-Ring Compounds; Captopril; Dipeptidyl-Peptidases and Tripeptidyl-Peptidases; Dose-Response Relationship, Drug; Drinking; Enalapril; Ramipril; Rats; Rats, Inbred Strains; Renin; Sodium Chloride | 1988 |
Disappearance of captopril-induced taste disturbance after substitution with angiotensin-converting-enzyme inhibitor HOE 498.
Topics: Angiotensin-Converting Enzyme Inhibitors; Bridged Bicyclo Compounds; Bridged-Ring Compounds; Captopril; Female; Humans; Hypertension; Middle Aged; Proline; Ramipril; Taste Disorders | 1985 |
Intrarenal generation of angiotensin II evaluated by an electrophysiological technique.
Topics: Angiotensin I; Angiotensin II; Angiotensin III; Animals; Bridged Bicyclo Compounds; Captopril; Female; Hydronephrosis; Juxtaglomerular Apparatus; Kidney; Membrane Potentials; Mice; Ramipril; Renin | 1987 |
[Effects of conversion enzyme inhibitors on the synthesis of angiotensin II by the isolated rat kidney].
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Bridged Bicyclo Compounds; Captopril; Kidney; Male; Ramipril; Rats; Rats, Inbred Strains | 1987 |
Converting enzyme inhibitor-induced changes of plasma angiotensinogen concentration in the rat.
Topics: Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Angiotensins; Animals; Bridged Bicyclo Compounds; Captopril; Enalapril; Liver; Male; Ramipril; Rats; Renin; Water-Electrolyte Balance | 1986 |
Systemic and regional hemodynamic profile of five angiotensin I converting enzyme inhibitors in the spontaneously hypertensive rat.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Bridged Bicyclo Compounds; Captopril; Enalapril; Indoles; Perindopril; Ramipril; Rats; Rats, Inbred SHR; Regional Blood Flow; Vascular Resistance | 1987 |
Effect of converting enzyme inhibitors on tissue converting enzyme and angiotensin II: therapeutic implications.
Topics: Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Bridged Bicyclo Compounds; Captopril; Enalapril; Injections, Intraventricular; Myocardium; Peptidyl-Dipeptidase A; Rabbits; Ramipril; Rats; Rats, Inbred SHR; Renin-Angiotensin System; Tissue Distribution | 1987 |
2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-(1S,3S,5S) -2-azabicyclo[3.3.0]octane-3-carboxylic acid (Hoe 498)--a new and highly effective angiotensin I converting enzyme inhibitor.
Topics: Adenylyl Cyclase Inhibitors; Angiotensin-Converting Enzyme Inhibitors; Animals; Bridged Bicyclo Compounds; Bridged-Ring Compounds; Captopril; Colforsin; Cyclic AMP; Dipeptides; Diterpenes; Enalapril; Heart; In Vitro Techniques; Kinetics; Lung; Membranes; Muscle Proteins; Myocardium; Peptidyl-Dipeptidase A; Rabbits; Ramipril; Rats; Rats, Inbred Strains | 1984 |
Inhibition of angiotensin converting enzyme by 2-[N-[(S)-1-carboxy-3-phenylpropyl]-L-alanyl]-(1S,3S,5S)-2-azabicyclo [3.3.0]octane-3-carboxylic acid (Hoe 498 diacid). Comparison with captopril and enalaprilat.
Topics: Angiotensin-Converting Enzyme Inhibitors; Bridged Bicyclo Compounds; Bridged-Ring Compounds; Captopril; Carboxypeptidases; Carboxypeptidases A; Dipeptides; Enalapril; Proline; Ramipril; Thermolysin; Zinc | 1984 |
Pharmacological properties of the new orally active angiotensin converting enzyme inhibitor 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl] -(1S,3S,5S)-2-azabicyclo[3.3.0]octane-3-carboxylic acid (Hoe 498).
Topics: Angiotensin I; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Bridged Bicyclo Compounds; Bridged-Ring Compounds; Captopril; Dipeptides; Dogs; Enalapril; Male; Ramipril; Rats; Rats, Inbred Strains; Species Specificity | 1984 |
Influence of the converting enzyme inhibitors Hoe 498, enalapril and captopril on vascular reactivity of isolated arterial preparations.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Aorta; Arteries; Bridged Bicyclo Compounds; Bridged-Ring Compounds; Captopril; Dipeptides; Enalapril; Guinea Pigs; In Vitro Techniques; Mesenteric Arteries; Norepinephrine; Proline; Pulmonary Artery; Ramipril | 1984 |
Effects of angiotensin II and ACE inhibitors on electrically stimulated noradrenaline release from superfused rat brain slices.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Brain; Bridged Bicyclo Compounds; Captopril; Clonidine; Dipeptides; Enalaprilat; In Vitro Techniques; Norepinephrine; Ramipril; Rats | 1984 |
Evidence for stimulation of neutrophil degranulation by selected angiotensin converting enzyme inhibitors in vitro.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cell Degranulation; Enalaprilat; Female; Humans; In Vitro Techniques; Lisinopril; Male; Middle Aged; Muramidase; Neutrophils; Peroxidase; Ramipril; Spectrophotometry; Zymosan | 1994 |
Comparison of renal hemodynamic effect of ramiprilat to captopril; possible role of kinins.
Topics: Animals; Biphenyl Compounds; Blood Pressure; Bradykinin; Captopril; Imidazoles; Kidney; Kinins; Losartan; Male; Rabbits; Ramipril; Renal Circulation; Tetrazoles | 1994 |
Renal 11 beta-hydroxysteroid dehydrogenase activity is enhanced by ramipril and captopril.
Topics: 11-beta-Hydroxysteroid Dehydrogenases; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Corticosterone; Fasting; Hydroxysteroid Dehydrogenases; Kidney; Male; Ramipril; Rats; Rats, Sprague-Dawley; Tritium | 1994 |
Dyspnoea, asthma, and bronchospasm in relation to treatment with angiotensin converting enzyme inhibitors.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Asthma; Bronchial Spasm; Captopril; Cough; Dyspnea; Enalapril; Female; Humans; Lisinopril; Male; Middle Aged; Ramipril | 1994 |
Do angiotensin converting enzyme inhibitors limit myocardial infarct size?
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Bradykinin; Captopril; Heart Rate; Injections, Intravenous; Male; Myocardial Infarction; Rabbits; Ramipril; Renin | 1993 |
Effect of inhibitors on the coordination geometries of cadmium at the metal sites in angiotensin-I-converting enzyme.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Binding Sites; Cadmium; Captopril; Carboxypeptidases; Gamma Rays; Lung; Peptidyl-Dipeptidase A; Protein Conformation; Rabbits; Ramipril; Spectrum Analysis; Zinc | 1995 |
Threshold sodium excretory and renal blood flow effects of angiotensin converting enzyme inhibition.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Differential Threshold; Diuresis; Hemodynamics; Imidazoles; Losartan; Natriuresis; Nephrectomy; Potassium; Ramipril; Rats; Rats, Wistar; Renal Circulation; Tetrazoles; Vasodilation | 1995 |
ACE inhibitors promote nitric oxide accumulation to modulate myocardial oxygen consumption.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Bradykinin Receptor Antagonists; Captopril; Coronary Vessels; Culture Techniques; Dogs; Enalaprilat; Kallikrein-Kinin System; Kininogens; Male; Microcirculation; Myocardium; Nitric Oxide; Nitrites; Oxygen Consumption; Ramipril | 1997 |
[A comparison of the effect of Capoten (captopril) and ramipril on the circadian profile of the arterial pressure and peripheral hemodynamics in patients with hypertension combined with diabetes mellitus].
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Captopril; Diabetes Mellitus; Drug Evaluation; Drug Therapy, Combination; Female; Hemodynamics; Humans; Hypertension; Hypoglycemic Agents; Male; Middle Aged; Myocardial Ischemia; Ramipril | 1996 |
Plasma ACE inhibition by five different ACE inhibitors.
Topics: Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzazepines; Captopril; Dogs; Enalapril; Lisinopril; Peptidyl-Dipeptidase A; Ramipril | 1998 |
Effect of ramiprilat or captopril on myocardial infarct size: assessment in canine models of ischemia alone and ischemia with reperfusion.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Coronary Circulation; Coronary Vessels; Disease Models, Animal; Dogs; Evaluation Studies as Topic; Heart Rate; Hemodynamics; Male; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion; Myocardial Reperfusion Injury; Ramipril | 1998 |
Probing the importance of spacial and conformational domains in captopril analogs for angiotensin converting enzyme activity.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Drug Design; Indicators and Reagents; Isomerism; Lung; Models, Molecular; Molecular Conformation; Peptidyl-Dipeptidase A; Proline; Rabbits; Ramipril; Structure-Activity Relationship | 1998 |
Competitive inhibition of glycylsarcosine transport by enalapril in rabbit renal brush border membrane vesicles: interaction of ACE inhibitors with high-affinity H+/peptide symporter.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Binding, Competitive; Captopril; Carrier Proteins; Cell Membrane; Dipeptides; Dose-Response Relationship, Drug; Enalapril; Fosinopril; Isoquinolines; Kidney; Kinetics; Lipid Metabolism; Lipids; Lisinopril; Male; Microvilli; Peptide Transporter 1; Quinapril; Rabbits; Ramipril; Symporters; Tetrahydroisoquinolines | 1999 |
Mixed-type inhibition of pulmonary angiotensin I-converting enzyme by captopril, enalaprilat and ramiprilat.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Binding, Competitive; Captopril; Enalaprilat; Humans; Kinetics; Lung; Macaca fascicularis; Peptidyl-Dipeptidase A; Ramipril; Rats; Rats, Sprague-Dawley; Swine | 1999 |
ACE inhibitor dosage at the time of listing predicts survival.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Enalapril; Female; Heart Failure; Heart Transplantation; Hemodynamics; Humans; Lisinopril; Male; Middle Aged; Prognosis; Ramipril; Survival Analysis | 2000 |
[Effects of angiotensin-converting enzyme (ACE) inhibitors on water-salt homeostasis in hypertensive patients living in Far North].
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Captopril; Cold Climate; Environmental Exposure; Homeostasis; Humans; Hypertension; Male; Prognosis; Ramipril; Siberia; Sodium; Water-Electrolyte Balance | 2000 |
Side effect of ACE inhibitor.
Topics: Angiotensin-Converting Enzyme Inhibitors; Burning Mouth Syndrome; Captopril; Humans; Ramipril | 1999 |
[ACE inhibition in patients with myocardial infarct and ventricular dysfunction: inappropriate application of therapy standards in patient samples].
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Clinical Trials as Topic; Confidence Intervals; Echocardiography; Enalapril; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Practice Guidelines as Topic; Ramipril; Registries; Sampling Studies; Surveys and Questionnaires; Time Factors; Ventricular Dysfunction, Left | 2001 |
What are 'tissue ACE inhibitors,' and should they be used instead of other ACE inhibitors?
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Cardiovascular Diseases; Clinical Trials as Topic; Enalapril; Heart Failure; Humans; Indoles; Isoquinolines; Myocardial Infarction; Perindopril; Prodrugs; Quinapril; Ramipril; Stroke; Stroke Volume; Tetrahydroisoquinolines; Treatment Outcome; Ventricular Dysfunction, Left | 2001 |
Angiotensin converting enzyme inhibitors and cough--a north Indian study.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cough; Enalapril; Female; Follow-Up Studies; Humans; Hypertension; Incidence; India; Indomethacin; Lisinopril; Male; Middle Aged; Prospective Studies; Ramipril; Risk Assessment | 1998 |
[Activity of the renin-angiotensin-aldosterone system and its impact on the effectiveness of treatment of chronic heart failure in patients with pulmonary tuberculosis].
Topics: Aldosterone; Angiotensin I; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Heart Failure; Humans; Radioimmunoassay; Ramipril; Renin; Renin-Angiotensin System; Tuberculosis, Pulmonary | 2001 |
[Effects of angiotensin-converting enzyme inhibitors and cosaar on quality of life of patients with pulmonary tuberculosis and chronic heart failure].
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Emotions; Heart Failure; Hemodynamics; Humans; Perindopril; Pulmonary Heart Disease; Quality of Life; Ramipril; Socioeconomic Factors; Surveys and Questionnaires; Tuberculosis, Pulmonary | 2001 |
[Prediction, screening and treatment of renal complications of diabetes].
Topics: Adult; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Cardiovascular Diseases; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diuretics; Female; Glomerular Filtration Rate; Humans; Hypertension; Male; Primary Prevention; Prognosis; Prospective Studies; Proteinuria; Ramipril; Renin-Angiotensin System; Risk Factors; Time Factors | 2001 |
Regression of ventricular and vascular hypertrophy: are there differences between structurally different angiotensin-converting enzyme inhibitors?
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta, Thoracic; Blood Pressure; Body Weight; Captopril; Circadian Rhythm; Dose-Response Relationship, Drug; Enalapril; Endothelin-1; Fosinopril; Hypertrophy, Left Ventricular; Male; Peptidyl-Dipeptidase A; Ramipril; Rats; Rats, Inbred SHR | 2002 |
HOPE study impact on ACE inhibitors use.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Canada; Captopril; Cardiovascular Diseases; Drug Utilization; Female; Humans; Logistic Models; Male; Ramipril; Time Factors | 2003 |
[Chronopharmacological approaches to the therapeutic prophylaxis of chronic cardiac insufficiency in type I diabetes mellitus].
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Female; Fosinopril; Glucose; Heart Failure; Hemodynamics; Humans; Immunologic Factors; Male; Oligopeptides; Ramipril; Time Factors | 2003 |
[Comparative assessment of antihypertensive effects of angiotensin-converting enzyme inhibitors ramipril and captopril in patients with hypertension in ambulatory settings].
Topics: Adult; Aged; Ambulatory Care; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure Monitoring, Ambulatory; Captopril; Female; Humans; Hypertension; Male; Middle Aged; Ramipril; Treatment Outcome | 2003 |
Ramipril-associated hepatotoxicity.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Chemical and Drug Induced Liver Injury, Chronic; Cholangiopancreatography, Endoscopic Retrograde; Cholestasis, Intrahepatic; Enalapril; Fosinopril; Humans; Jaundice; Liver; Liver Cirrhosis, Biliary; Liver Function Tests; Male; Middle Aged; Ramipril | 2003 |
The problem of underdosing of angiotensin-converting enzyme inhibitors is markedly overrated: results from a study of patients discharged from hospital after an acute myocardial infarction.
Topics: Acute Disease; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Utilization; Enalapril; Evaluation Studies as Topic; Female; Hospitalization; Humans; Lisinopril; Male; Myocardial Infarction; Patient Discharge; Pharmacoepidemiology; Ramipril; Randomized Controlled Trials as Topic | 2004 |
Practical recommendations for the use of ACE inhibitors, beta-blockers, aldosterone antagonists and angiotensin receptor blockers in heart failure: putting guidelines into practice.
Topics: Adrenergic beta-Antagonists; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzopyrans; Biphenyl Compounds; Bisoprolol; Captopril; Carbazoles; Carvedilol; Drug Therapy, Combination; Enalapril; Ethanolamines; Evidence-Based Medicine; Guideline Adherence; Heart Failure; Humans; Indoles; Lisinopril; Metoprolol; Mineralocorticoid Receptor Antagonists; Nebivolol; Practice Guidelines as Topic; Propanolamines; Ramipril; Spironolactone; Stroke Volume; Tetrazoles; Valine; Valsartan | 2005 |
Validated ligand mapping of ACE active site.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Catalytic Domain; Computer Simulation; Crystallography, X-Ray; Enalapril; Humans; Ligands; Lisinopril; Models, Molecular; Molecular Conformation; Molecular Structure; Peptidyl-Dipeptidase A; Ramipril; Zinc | 2005 |
Differential antiplatelet effects of angiotensin converting enzyme inhibitors: comparison of ex vivo platelet aggregation in cardiovascular patients with ramipril, captopril and enalapril.
Topics: Adenosine Diphosphate; Aged; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Captopril; Cardiovascular Diseases; Clopidogrel; Collagen; Coronary Artery Disease; Electric Impedance; Enalapril; Female; Fibrinolytic Agents; Germany; Humans; Hypertension; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Prospective Studies; Ramipril; Ticlopidine; Treatment Outcome | 2006 |
Captopril inhibits the oxidative modification of apolipoprotein B-100 caused by myeloperoxydase in a comparative in vitro assay of angiotensin converting enzyme inhibitors.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Apolipoprotein B-100; Apolipoproteins B; Atherosclerosis; Captopril; Enalapril; Fosinopril; Humans; Hydrogen Peroxide; Hypochlorous Acid; Lipoproteins, LDL; Lisinopril; Oxidation-Reduction; Peroxidase; Ramipril; Recombinant Proteins | 2006 |
Differences between zofenopril and ramipril, two ACE inhibitors, on cough induced by citric acid in guinea pigs: role of bradykinin and PGE2.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Bradykinin B2 Receptor Antagonists; Bronchoalveolar Lavage Fluid; Captopril; Citric Acid; Cough; Dinoprostone; Dose-Response Relationship, Drug; Drug Synergism; Guinea Pigs; Male; Ornithine; Ramipril; Sulfonamides | 2010 |
Effects of zofenopril and ramipril on cough reflex responses in anesthetized and awake rabbits.
Topics: Anesthesia, Intravenous; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Captopril; Citric Acid; Consciousness; Cough; Drug Evaluation, Preclinical; Injections, Intravenous; Male; Rabbits; Ramipril; Reflex | 2010 |
Neuroprotective effect of ACE inhibitors in glutamate - induced neurotoxicity: rat neuron culture study.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Newborn; Captopril; Cell Survival; Cells, Cultured; Glutamic Acid; Neurons; Neuroprotective Agents; Neurotoxicity Syndromes; Perindopril; Ramipril; Rats; Rats, Sprague-Dawley | 2011 |
Mitigation of experimental radiation nephropathy by renin-equivalent doses of angiotensin converting enzyme inhibitors.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Biomarkers; Bone Marrow Transplantation; Calibration; Captopril; Enalapril; Fosinopril; Kidney; Kidney Diseases; Lisinopril; Male; Radiation Injuries; Ramipril; Rats; Renin; Renin-Angiotensin System; Whole-Body Irradiation | 2014 |
Comparing individual angiotensin-converting enzyme inhibitors with losartan in the risk of hospitalization for pneumonia and related mortality: a nationwide cohort study.
Topics: Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cohort Studies; Enalapril; Female; Hospitalization; Humans; Incidence; Losartan; Male; Middle Aged; Pneumonia; Ramipril; Risk; Taiwan | 2015 |
Zofenopril and Ramipril in Combination with Acetyl Salicylic Acid in Postmyocardial Infarction Patients with Left Ventricular Systolic Dysfunction: A Retrospective Analysis of the SMILE-4 Randomized, Double-Blind Study in Diabetic Patients.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Captopril; Cardiovascular Diseases; Diabetic Cardiomyopathies; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Ramipril; Randomized Controlled Trials as Topic; Retrospective Studies; Systole; Ventricular Dysfunction, Left | 2016 |
Zofenopril Protects Against Myocardial Ischemia-Reperfusion Injury by Increasing Nitric Oxide and Hydrogen Sulfide Bioavailability.
Topics: Animals; Antihypertensive Agents; Biological Availability; Blotting, Western; Captopril; Cystathionine beta-Synthase; Cystathionine gamma-Lyase; Heart; Hydrogen Sulfide; Mice; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Nitric Oxide; Nitric Oxide Synthase Type III; Ramipril; Random Allocation; Regional Blood Flow; Reverse Transcriptase Polymerase Chain Reaction; Sulfurtransferases; Swine; Swine, Miniature; Troponin I | 2016 |
Early Treatment With Zofenopril and Ramipril in Combination With Acetyl Salicylic Acid in Patients With Left Ventricular Systolic Dysfunction After Acute Myocardial Infarction: Results of a 5-Year Follow-up of Patients of the SMILE-4 Study.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Captopril; Chi-Square Distribution; Clinical Trials, Phase III as Topic; Disease-Free Survival; Drug Administration Schedule; Drug Therapy, Combination; Early Medical Intervention; Female; Follow-Up Studies; Hospitalization; Humans; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Ramipril; Randomized Controlled Trials as Topic; Recovery of Function; Retrospective Studies; Risk Factors; Systole; Time Factors; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Function, Left | 2017 |
A Comparative Study on the Memory-Enhancing Actions of Oral Renin-Angiotensin System Altering Drugs in Scopolamine-Treated Mice.
Topics: Administration, Oral; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Humans; Losartan; Male; Maze Learning; Memory Disorders; Memory, Long-Term; Memory, Short-Term; Mice; Muscarinic Antagonists; Ramipril; Renin-Angiotensin System; Scopolamine; Spatial Memory | 2019 |
Enhancement of EPC migration by high-dose lisinopril is superior compared to captopril and ramipril.
Topics: Captopril; Endothelial Progenitor Cells; Humans; Leukocytes, Mononuclear; Lisinopril; Ramipril | 2021 |